Biliang Chen

2.8k total citations
85 papers, 1.9k citations indexed

About

Biliang Chen is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Biliang Chen has authored 85 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 14 papers in Immunology and 14 papers in Cancer Research. Recurrent topics in Biliang Chen's work include Endometrial and Cervical Cancer Treatments (8 papers), RNA Interference and Gene Delivery (7 papers) and Prenatal Screening and Diagnostics (7 papers). Biliang Chen is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), RNA Interference and Gene Delivery (7 papers) and Prenatal Screening and Diagnostics (7 papers). Biliang Chen collaborates with scholars based in China, United States and Czechia. Biliang Chen's co-authors include Xiaoyan Xin, Shujuan Liu, Xiangdong Ma, Hong Yang, Jia Li, Guoqing Cai, Jianfang Zhang, Wei Zou, Fuxing Zhou and Jiajia Ma and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Biliang Chen

84 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Biliang Chen China 26 1.1k 497 345 339 188 85 1.9k
Anne M. Friel Ireland 19 869 0.8× 535 1.1× 162 0.5× 526 1.6× 185 1.0× 30 1.6k
Nina Ditsch Germany 24 513 0.5× 310 0.6× 234 0.7× 555 1.6× 202 1.1× 116 1.8k
Shi‐Wen Jiang China 25 761 0.7× 291 0.6× 282 0.8× 215 0.6× 300 1.6× 102 1.8k
Yinglu Guo China 27 1.1k 1.0× 419 0.8× 221 0.6× 361 1.1× 144 0.8× 75 2.2k
Patrícia Ashton‐Prolla Brazil 30 1.2k 1.2× 712 1.4× 151 0.4× 1.1k 3.1× 110 0.6× 158 2.9k
Panagiotis Christopoulos Greece 23 469 0.4× 202 0.4× 317 0.9× 329 1.0× 265 1.4× 82 1.8k
Thomas Vrekoussis Greece 24 471 0.4× 335 0.7× 413 1.2× 268 0.8× 414 2.2× 66 1.7k
Sandra L. Grimm United States 23 796 0.8× 227 0.5× 225 0.7× 537 1.6× 93 0.5× 75 1.7k
Linda E. Kelemen United States 27 632 0.6× 353 0.7× 174 0.5× 638 1.9× 505 2.7× 55 2.2k
Marek Spaczyński Poland 23 493 0.5× 252 0.5× 299 0.9× 567 1.7× 318 1.7× 112 1.8k

Countries citing papers authored by Biliang Chen

Since Specialization
Citations

This map shows the geographic impact of Biliang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biliang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biliang Chen more than expected).

Fields of papers citing papers by Biliang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biliang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biliang Chen. The network helps show where Biliang Chen may publish in the future.

Co-authorship network of co-authors of Biliang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Biliang Chen. A scholar is included among the top collaborators of Biliang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biliang Chen. Biliang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Biliang, Hongwei Zhao, Li Wang, et al.. (2023). Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14‐year multicenter study. Cancer Medicine. 12(19). 19617–19632. 3 indexed citations
2.
Chen, Biliang, et al.. (2023). The long‐term outcomes of vaginoplasty using acellular porcine small intestinal submucosa grafts in patients with Mayer–Rokitansky–Küster–Hauser syndrome: A case series. BJOG An International Journal of Obstetrics & Gynaecology. 130(6). 645–652. 2 indexed citations
3.
Yang, Xiaoshan, Yunge Gao, Yanhong Lv, et al.. (2023). O‑GlcNAcylation mediates endometrial cancer progression by regulating the Hippo‑YAP pathway. International Journal of Oncology. 63(2). 10 indexed citations
4.
Liang, Cong, Shan Kang, Weili Li, et al.. (2023). Risk factors for and delayed recognition of genitourinary fistula following radical hysterectomy for cervical cancer: a population-based analysis. Journal of Gynecologic Oncology. 34(2). e20–e20. 3 indexed citations
5.
Li, Chunyan, et al.. (2021). Screening and Identification of a Specific Binding Peptide to Ovarian Cancer Cells from a Phage-Displayed Peptide Library. International Journal of Peptide Research and Therapeutics. 27(3). 1741–1749. 2 indexed citations
6.
Fang, Cheng, Wenhui Li, Xing Liu, et al.. (2021). Potent antitumor activity of a glutamyltransferase-derived peptide via an activation of oncosis pathway. Scientific Reports. 11(1). 16507–16507. 3 indexed citations
7.
Gao, Tian, Xiaohong Zhang, Jing Zhao, et al.. (2019). SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer. Cancer Letters. 469. 89–101. 129 indexed citations
8.
Zhang, Ying, et al.. (2019). Neurofibromin 1 expression is negatively correlated with malignancy and prognosis of epithelial ovarian cancer.. Europe PMC (PubMed Central). 12(5). 1702–1712. 7 indexed citations
9.
Zhou, Dongmei, Jun Liu, Fang Liu, et al.. (2019). A novel FoxM1-PSMB4 axis contributes to proliferation and progression of cervical cancer. Biochemical and Biophysical Research Communications. 521(3). 746–752. 6 indexed citations
10.
Song, Tingting, et al.. (2019). Non-invasive prenatal testing for detection of trisomy 13, 18, 21 and sex chromosome aneuploidies in 8594 cases. Ginekologia Polska. 90(5). 270–273. 9 indexed citations
11.
Guo, Li, Yu Liu, Ying Guo, Yongkang Yang, & Biliang Chen. (2018). MicroRNA-423–5p inhibits the progression of trophoblast cells via targeting IGF2BP1. Placenta. 74. 1–8. 25 indexed citations
12.
Zhou, Fuxing, et al.. (2016). Elevated glucose levels impair the WNT/β-catenin pathway via the activation of the hexosamine biosynthesis pathway in endometrial cancer. The Journal of Steroid Biochemistry and Molecular Biology. 159. 19–25. 25 indexed citations
13.
Wang, Ming‐Yi, Biliang Chen, Jian Wang, Xiangdong Ma, & Yu Wang. (2014). Nonsurgical Management of Live Tubal Ectopic Pregnancy by Ultrasound-Guided Local Injection and Systemic Methotrexate. Journal of Minimally Invasive Gynecology. 21(4). 642–649. 16 indexed citations
14.
15.
Yang, Hong, Wei Zou, & Biliang Chen. (2013). Overexpression of CD147 in ovarian cancer is initiated by the hypoxic microenvironment. Cell Biology International. 37(10). 1139–1142. 19 indexed citations
16.
Yang, Hong & Biliang Chen. (2012). CD147 in Ovarian and Other Cancers. International Journal of Gynecological Cancer. 23(1). 2–8. 22 indexed citations
17.
Ma, Xiangdong, et al.. (2011). Antiproliferation and apoptosis induced by Bisdemethoxycurcumin in human ovarian cancer cell SKOV3. Journal of Medicinal Plants Research. 5(12). 2499–2507. 1 indexed citations
18.
Ma, Xiangdong, et al.. (2011). Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer. Gynecologic Oncology. 122(3). 554–559. 27 indexed citations
19.
Wei, Li, Tao Xue, Jian Song, et al.. (2009). Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer. International Journal of Cancer. 125(4). 791–806. 59 indexed citations
20.
Chen, Biliang. (2007). Progress in research on female reproductive toxicity of methoxychlor. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne M. Friel Breakdown of academic impact, for papers by Nina Ditsch Breakdown of academic impact, for papers by Shi‐Wen Jiang Breakdown of academic impact, for papers by Yinglu Guo Breakdown of academic impact, for papers by Patrícia Ashton‐Prolla Breakdown of academic impact, for papers by Panagiotis Christopoulos Breakdown of academic impact, for papers by Thomas Vrekoussis Breakdown of academic impact, for papers by Sandra L. Grimm Breakdown of academic impact, for papers by Linda E. Kelemen Breakdown of academic impact, for papers by Marek Spaczyński
Rankless by CCL
2026